Akintunde Olatokumbo Bello - Jun 10, 2025 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Elana Brockmann, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
3
Date filed
6/12/2025, 04:33 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bello Akintunde Olatokumbo Director 828 WINTER STREET, SUITE 300, WALTHAM /s/ Elana Brockmann, Attorney-in-Fact 2025-06-12 0002070709

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney